Neopterin as a prognostic parameter in patients with squamous-cell carcinomas of the oral cavity

✍ Scribed by Christian Murr; Jens Berchtold; Burghard Norer; Ernst Waldhart; Helmut Wachter; Dietmar Fuchs

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: French
• Weight: 80 KB
• Volume: 79
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/(sici)1097-0215(19981023)79:5<476::aid-ijc5>3.0.co;2-y

✦ Synopsis

Concentrations of neopterin, which is produced by human monocytes/macrophages upon stimulation by interferon-␥, were measured in urine specimens in 23 patients with squamous-cell carcinoma of the oral cavity at diagnosis and in 12 treated patients with the same disease when recurrence of the tumor was recognized. Tumor histology and routine laboratory parameters were concomitantly determined. Urinary neopterin values showed no statistically significant correlation with tumor differentiation, tumor size or patient age, but they were significantly higher in patients with a recurrent tumor. Patients were followed for up to 4 years, and the ability of all variables to predict fatal outcome was assessed. In univariate analysis, only neopterin (p ‫؍‬ 0.01) and the variable recurrent vs. first-diagnosed tumor were significant predictors of survival. In multivariate analysis, a combination of neopterin (p F 0.01) and the variable recurrent vs. firstdiagnosed tumor (p ‫؍‬ 0.06) was found to jointly predict survival. Thus, urinary neopterin concentrations provide valuable prognostic information in patients with squamous-cell carcinoma of the oral cavity.